Wednesday, June 10, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 23 of 1,261
  1. US 12378231

    Small molecules as monoacylglycerol lipase (MAGL) inhibitors, compositions and use thereof

    APOGEE PHARMACEUTICALS, INC. Β· Granted Aug 5, 2025 Β· Expires Jul 31, 2045

    granted
  2. US 12378280

    Deoxynucleic guanidines (DNG)-modified oligonucleotides and methods of synthesizing deoxynucleic guanidine strands

    Northwestern University Β· Granted Aug 5, 2025 Β· Expires Jul 31, 2045

    granted
  3. US 12378557

    Treatment of sepsis with PCSK9 and LDLR modulators

    REGENERON PHARMACEUTICALS, INC. Β· Granted Aug 5, 2025 Β· Expires Jul 31, 2045

    granted
  4. US 12378288

    Multimeric bicyclic peptide ligands

    BicycleTx Limited Β· Granted Aug 5, 2025 Β· Expires Jul 31, 2045

    granted
  5. US 12379385

    Methods of treating patients afflicted with irritable bowel syndrome, inflammatory bowel disease or chronic gastrointestinal functional disorders based on assessment of intestinal barrier function

    Maximus Diagnostic Technologies LLC Β· Granted Aug 5, 2025 Β· Expires Jul 31, 2045

    granted
  6. US 12378553

    Modified double-stranded RNA agents

    Alnylam Pharmaceuticals, Inc. Β· Granted Aug 5, 2025 Β· Expires Jul 31, 2045

    granted
  7. US 12377069

    Compounds, compositions, methods of using, and methods for preparing compounds

    THE INSTITUTE FOR STEM CELL BIOLOGY AND REGENERATIVE MEDICINE (INSTEM) Β· Granted Aug 5, 2025 Β· Expires Jul 31, 2045

    granted
  8. US 12378256

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited Β· Granted Aug 5, 2025 Β· Expires Jul 31, 2045

    granted
  9. US 12378560

    Sequence multiplicity within spherical nucleic acids

    Northwestern University Β· Granted Aug 5, 2025 Β· Expires Jul 31, 2045

    granted
  10. US 12377186

    Antimicrobial biopolymer compositions, methods of synthesis, and applications of use

    Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Aug 5, 2025 Β· Expires Jul 31, 2045

    granted
  11. US 12378245

    Crystalline forms of an RSK inhibitor

    PHOENIX MOLECULAR DESIGNS Β· Granted Aug 5, 2025 Β· Expires Jul 31, 2045

    granted
  12. US 12377112

    Methods of treating neurocognitive disorders, chronic pain and reducing inflammation

    Compass Pathfinder Limited Β· Granted Aug 5, 2025 Β· Expires Jul 31, 2045

    granted
  13. US 12377104

    Methods for treating a fatty liver disease

    Madrigal Pharmaceuticals, Inc. Β· Granted Aug 5, 2025 Β· Expires Jul 31, 2045

    granted
  14. US 12377051

    Microspheres for extended, controlled release of therapeutic agents

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Aug 5, 2025 Β· Expires Jul 31, 2045

    granted
  15. US 12377093

    Pyruvate kinase activators for use in therapy

    Agios Pharmaceuticals, Inc. Β· Granted Aug 5, 2025 Β· Expires Jul 31, 2045

    granted
  16. US 12377082

    Nicorandil derivatives

    UNICYCIVE THERAPEUTICS, INC. Β· Granted Aug 5, 2025 Β· Expires Jul 31, 2045

    granted
  17. US 12378248

    A1 adenosine receptor agonists and methods of use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Aug 5, 2025 Β· Expires Jul 31, 2045

    granted
  18. US 12378337

    Lipid nanodiscs solubilized through poly(acrylic acid-co-styrene) copolymers

    The Regents of the University of California Β· Granted Aug 5, 2025 Β· Expires Jul 31, 2045

    granted
  19. US 12377252

    Implantation devices, system, and methods

    Vertex Pharmaceuticals Incorporated Β· Granted Aug 5, 2025 Β· Expires Jul 31, 2045

    granted
  20. US 12378195

    Aminated psilocybin derivatives and methods of using

    Enveric Biosciences Canada Inc. Β· Granted Aug 5, 2025 Β· Expires Jul 31, 2045

    granted
  21. US 12378199

    Rigidified pentadentate chelating agents useful for the [Al18F]2+ labelling of biomolecules

    UNIVERSITΓ€ DEGLI STUDI DEL PIEMONTE ORIENTALE β€œA. AVOGADRO” Β· Granted Aug 5, 2025 Β· Expires Jul 31, 2045

    granted
  22. US 12377150

    Exon skipping oligomer conjugates for muscular dystrophy

    Sarepta Therapeutics, Inc. Β· Granted Aug 5, 2025 Β· Expires Jul 31, 2045

    granted
  23. US 12377151

    Immobilized endoglycosidase fusion protein and use thereof

    GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. Β· Granted Aug 5, 2025 Β· Expires Jul 31, 2045

    granted
  24. US 12378241

    Pyridine derivative as FGFR and VEGFR dual inhibitors

    CGeneTech (Suzhou, China) CO., Ltd. Β· Granted Aug 5, 2025 Β· Expires Jul 31, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.